These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 644545)

  • 41. Letter: Interstitial pneumonia after prolonged treatment with cyclophosphamide.
    Am Rev Respir Dis; 1973 Dec; 108(6):1453-4. PubMed ID: 4751739
    [No Abstract]   [Full Text] [Related]  

  • 42. Fatal pneumopathy after cytostatic treatment for leukemia in children.
    Müller KM; Menne R; Hüther W; Gröbe H
    J Cancer Res Clin Oncol; 1979 Jul; 94(3):287-94. PubMed ID: 289647
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bronchiolitis interstitial pneumonitis: a pathologic study of 31 lung biopsies with features intermediate between bronchiolitis obliterans organizing pneumonia and usual interstitial pneumonitis, with clinical correlation.
    Mark EJ; Ruangchira-urai R
    Ann Diagn Pathol; 2008 Jun; 12(3):171-80. PubMed ID: 18486892
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pulmonary effects of cytotoxic agents other than bleomycin.
    Twohig KJ; Matthay RA
    Clin Chest Med; 1990 Mar; 11(1):31-54. PubMed ID: 1691069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progressive lupus glomerulonephritis. Treatment with prednisone and combined prednisone and cyclophosphamide.
    Donadio JV; Holley KE; Ferguson RH; Ilstrup DM
    Mayo Clin Proc; 1976 Aug; 51(8):484-94. PubMed ID: 950801
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies.
    Volkmann ER; Tashkin DP
    Ann Am Thorac Soc; 2016 Nov; 13(11):2045-2056. PubMed ID: 27560196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The histopathology of pulmonary reactions to drugs.
    Smith GJ
    Clin Chest Med; 1990 Mar; 11(1):95-117. PubMed ID: 1691070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pulmonary fibrosis associated with tocainide: report of a case with literature review.
    Feinberg L; Travis WD; Ferrans V; Sato N; Bernton HF
    Am Rev Respir Dis; 1990 Feb; 141(2):505-8. PubMed ID: 2137316
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclophosphamide-induced lung damage in mice: protection by a small preliminary dose.
    Collis CH; Wilson CM; Jones JM
    Br J Cancer; 1980 Jun; 41(6):901-7. PubMed ID: 7426315
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Lung infiltrations in Hodgkin lymphoma].
    Ciurea-Löchel A; Ciurea A; Stey C; Pestalozzi B
    Praxis (Bern 1994); 2001 Aug; 90(31-32):1307-11. PubMed ID: 11519195
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A controlled trial of cyclophosphamide in the treatment of proliferative glomerulonephritis.
    Koelz AM; Morley AR; Uldall PR; Kerr DN
    Proc Eur Dial Transplant Assoc; 1975; 11():491-9. PubMed ID: 1105560
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fatal pulmonary toxicity after a single dose of cyclophosphamide.
    Gupta S; Mahipal A
    Pharmacotherapy; 2007 Apr; 27(4):616-8. PubMed ID: 17381391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early stage of fulminant idiopathic pulmonary fibrosis cured by intense combination therapy using cyclophosphamide, vincristine, and prednisone.
    Meuret G; Fueter R; Gloor F
    Respiration; 1978; 36(4):228-33. PubMed ID: 674871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Chromosome aberrations in children with glomerulonephritis treated with cyclophosphamide].
    Strózyński H; Bodalski J; Narebska E
    Pol Tyg Lek; 1980 Dec; 35(49):1893-5. PubMed ID: 7243646
    [No Abstract]   [Full Text] [Related]  

  • 55. 'Pulse' methylprednisolone and cyclophosphamide therapy in idiopathic rapidly progressive glomerulonephritis.
    Friedman G; Granot H; Koplovic Y; Friedlander M
    Postgrad Med J; 1981 Jan; 57(663):54-6. PubMed ID: 7279827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methotrexate-induced pneumonitis: appearance four weeks after discontinuation of treatment.
    Elsasser S; Dalquen P; Soler M; Perruchoud AP
    Am Rev Respir Dis; 1989 Oct; 140(4):1089-92. PubMed ID: 2802369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pulmonary, pleural and thoracic changes complicating chemotherapy.
    Tucker AS; Newman AJ; Alvorado C
    Radiology; 1977 Dec; 125(3):805-9. PubMed ID: 928714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bronchoalveolar lavage cellular analysis and gallium lung scan in the assessment of patients with amiodarone-induced pneumonitis.
    Xaubet A; Roca J; Rodriguez-Roisin R; Herranz J; Marin A; Lomeña F; Montserrat JM; Agustí-Vidal A
    Respiration; 1987; 52(4):272-80. PubMed ID: 3438590
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Morphogenesis and pathogenesis of chronic lung diseases. XVIII. Influence of cyclophosphamide on the evolution toward fibrosis of experimental lung granulomas: a quantitative analysis.
    Eskenasy A; Popescu E
    Med Interne; 1982; 20(4):299-306. PubMed ID: 6985499
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute pulmonary disease caused by phenytoin.
    Michael JR; Rudin ML
    Ann Intern Med; 1981 Oct; 95(4):452-4. PubMed ID: 7283296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.